Clovis Oncology

NCT01074970

PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations

NCT01124786

A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)

NCT01233375

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

NCT02109016

A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations

NCT02147990

Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer

NCT02202746

A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

NCT02678182

Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial

NCT02505048

A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature

NCT02705339

Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)

NCT02873962

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

NCT02935634

A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer

NCT02747797

Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations

NCT03338790

An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

NCT03476798

Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium

NCT03413995

Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations

NCT03654833

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

NCT03617679

Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer

NCT03533946

Rucaparib in Nonmetastatic prOstAte With BRCAness

NCT03694262

The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)

NCT03899155

Pan Tumor Rollover Study

NCT03958045

Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma

NCT04624178

A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma